Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival

Publication | Closed Access

DOI

128

Citations

References

2008

Year

David S. Alberts, Christian Marth, Ronald D. Alvarez, Gary A. Johnson, Mariusz Bidziński, David Kardatzke, Williamson Z. Bradford, Jeff Loutit, David H. Kirn, Mary C. Clouser,

Gynecologic Oncology

Progression-free SurvivalMedicineCancer ManagementGynecologyFirst-line TreatmentCancer TreatmentOncologyRadiation OncologyGynecology OncologyPhase 3Ovarian Cancer